Campingcar Besinov BAKER TILLY SPIESS S.A. UBS AG UNICREDIT AG

Campingcar Besinov BAKER TILLY SPIESS S.A. UBS AG UNICREDIT AG

THE SWISS CRIMES BEHIND THE NEUTRAL FACADE & THE CRIMES WITH THE GLOBAL RESOURCES
 
RegisterPublicationsSearchPETER ANDELHomeLog inFAQ

Share | 
 

 Dr. Peter D. Suzdak

Go down 
AuthorMessage
Admin
Admin
Admin
avatar

Female
Number of posts : 3493
Birthday : 1952-04-20
Age : 66
Reputation : 0
Points : 9658
Registration date : 2007-04-25

PostSubject: Dr. Peter D. Suzdak   Thu Jan 11, 2018 6:09 pm




Dr. Peter D. Suzdak, Ph.D, has been the Chief Executive Officer of Rexahn Pharmaceuticals, Inc. since February 4, 2013. Dr. Suzdak served as the Chief Scientific Officer of Corridor Pharmaceuticals, Inc. He was the Founder of Cardioxyl Pharmaceuticals, Inc. and served as its Chief Executive Officer and President until 2008. Dr. Suzdak Co-Founded Artesian Therapeutics Inc. and served as its President and Chief Executive Officer. Dr. Suzdak served as the Senior Vice President ... of Research and Development at Guilford Pharmaceuticals from 1995 to 2002. He was responsible for all Pharmaceuticals Drug Discovery, Preclinical Development and Clinical Development activities at Guilford. Dr. Suzdak was responsible for establishing an integrated Drug Discovery and development function at Guilford and building an extensive technology and intellectual property platform around multiple novel biological targets. Prior to joining Guilford, Dr. Suzdak held various positions at Novo-Nordisk A/S in Copenhagen, Denmark from 1988 to 1995, including Director of Neurobiology Research. Dr. Suzdak also oversaw the creation of an accelerated Lead Product Selection (LPS) process and an accelerated Drug Discovery process (B2B1000) while at Guilford. Dr. Suzdak was involved in multiple drug discovery and development collaborations with major pharmaceutical companies in the U.S. and Europe, including Abbott Laboratories which resulted in the successful discovery, clinical development, approval and marketing of the novel anti-epileptic Gabatril(R). Prior thereto, Dr. Suzdak was a Pharmacology Research Associate in the Clinical Neuroscience Branch of the National Institute of Mental Health in Bethesda, in the laboratory of Dr. Steven M. Paul from 1985 to 1988. Dr. Suzdak has held multiple positions in the Pharmaceutical industry over the past 17 years. He is a research and development executive with more than 19 years experience in U.S. and European based pharmaceutical companies. He has been a Director of Rexahn Pharmaceuticals, Inc. since June 2013. Dr. Suzdak served as a Director of Aeolus Pharmaceuticals Inc. (Incara Pharmaceuticals Corp.) from June 2004 to May 2013. Dr. Suzdak served as a Director of Cardioxyl Pharmaceuticals, Inc. Dr. Suzdak served as a Director of Artesian Therapeutics Inc. He is an Author on 80 peer-reviewed publications and eight, invited book chapters. He has more than 24 years of experience with U.S. and European-based pharmaceutical companies and has stewarded the filing of 15 IND applications and three NDA/sNDAs. Dr. Suzdak received his Ph.D. in Pharmacology and Toxicology from the University of Connecticut and a B.S. in Pharmacy from St. Johns University.
Back to top Go down
View user profile http://www.campingcarbesinov.com
 
Dr. Peter D. Suzdak
Back to top 
Page 1 of 1
 Similar topics
-
» Welcome to Peter Phia Xiong Home page Forum
» Peter Phia Xiong (Tshuab Qeej )
» Low carb diet is significantly helping my migraines
» Peter Phia Xiong hai lus Druag
» Peter Parker (Spider-Man) Meets The-One-Above-All

Permissions in this forum:You cannot reply to topics in this forum
Campingcar Besinov BAKER TILLY SPIESS S.A. UBS AG UNICREDIT AG :: BAKER TILLY VIRCHOV KRAUSE DAVID JOHN JAMES BAKER TILLY AND MR. BERLUSCONI-
Jump to: